The highest levels of healthcare efficacy independently proven in published clinical studies and independent testing by leading researchers worldwide.

Peer-Reviewed Published Hospital Studies

Year of Publication Hospital | Healthcare System Lead Investigator(s) Scope Journal
2022Wits University Donald Gordon Medical Center, Johannesburg, South AfricaDr. Warren Lowman, Clinical Microbiologist and IPC SpecialistCarbapenam-resistant enterobacterales (CRE)Journal of Hospital Infection
Read
2020Hospital Infantil de México Federico Gómez, Mexico City, MexicoDaniela De la Rosa-Zamboni MS, MD, Department of Hospital EpidemiologyMRSAFrontiers in Microbiology
Read
2020Università degli Studi di Siena, Siena, ItalyGabriele Messina MD, PhD, MSc EpidemiologyEnvironmental bioburden – operating roomsThe European Journal of Public Health
Read
2020Università degli Studi di Siena, Siena, ItalyGabriele Messina MD, PhD, MSc EpidemiologyEnvironmental bioburden – patient roomsThe European Journal of Public Health
Read
2019Canisius Wilhelmina Hospital (CWZ), Nijmegen, The NetherlandsAndreas Voss, MD, PhD, Medical MicrobiologyCandida aurisMycoses
Read
2018St. Mary’s Hospital for ChildrenMarianne Pavia MS, BS, CIC, FAPIC, Director of Infection PreventionViruses: Influenza, rhinovirus, enterovirus, and human metapneumovirusAmerican Journal of Infection Control
Read
2018The University of Iowa Hospitals and ClinicsVincent Masse, MD, University of Iowa Carver College of Medicine and University of Iowa Hospitals and ClinicsMRSA and C. difficileAntimicrobial Resistance & Infection Control
Read
2017The Johns Hopkins Health SystemLisa Maragakis, MD, MPH, Senior Director of Infection Prevention and Associate Professor of MedicinePatient and healthcare worker satisfaction surveyAmerican Journal of Infection Control
Read
2017Hospital of the University of PennsylvaniaDavid Pegues, MD, Professor of MedicineC. difficileInfection Control and Hospital Epidemiology
Read
2016The Johns Hopkins Health SystemLisa Maragakis, MD, MPH, Senior Director of Infection Prevention and Associate Professor of MedicineCarbapenem-resistant Enterobacteriaceae (CRE)Infection Control and Hospital Epidemiology
Read
2016UNC School of MedicineWilliam Rutala, MS, MPH, PhD, Director of Hospital Epidemiologymethicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Klebsiella pneumoniae (CRKP)Infection Control and Hospital Epidemiology
Read
2014UNC School of MedicineWilliam Rutala, MS, MPH, PhD, Director of Hospital Epidemiologymethicillin-resistant Staphylococcus aureus (MRSA)Infection Control and Hospital Epidemiology
Read

Poster Presentations and Laboratory Studies

Year Presented Hospital | Healthcare System Lead Investigator(s) Scope Setting
2019Università degli Studi di Siena, Siena, ItalyGabriele Messina MD, PhD, MSc EpidemiologyCandida aurisLab Study
2018Louis Stokes Veterans Affairs Medical CenterCurtis Donskey, MD, Professor of Medicine, Case Western Reserve University and Staff Physician, Infectious Diseases, Jennifer Cadnum, Research Service, Louis Stokes Veterans Affairs Medical CenterCandida aurisLab Study
Read
2017Cardiff University, WalesJean Yves Maillard, MD, Professor of Pharmaceutical Microbiology, Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff UniversityClostridium difficile Staphylococcus aureus Methicillin-resistant Staphylococcus aureus Enterococcus faecalis Vancomycin resistant E. faecalis Klebsiella pneumoniae A. baumannii Candida aurisLab Study
2016Cleveland ClinicCurtis Donskey, MD, Professor of Medicine, Case Western Reserve University and Staff Physician, Infectious Diseases Section Abhishek Deshpande, MD, PhD, Assistant Professor of MedicineC. difficile, MRSA, vancomycin-resistant Enterococcus (VRE)SHEA 2016
2015The Women’s Hospital – Deaconess Health SystemSonya Mauzey, RN, BS, CIC, Infection PreventionistPseudomonas aeruginosaAPIC 2015 (poster presentation)
2015University of ArizonaCharles Gerba, PhD, Professor, Microbiology & Environmental Sciences, University of ArizonaC. difficile spores, MS-2 virus and MRSAAPIC 2015

99.99% inactivation of over 35 high-risk microorganisms in 5 minutes from 2.44 meters away - and SARS-CoV-2 at 3.65 meters.

Independently proven efficacy at real-world times and distances. Over 35 independent laboratory tests proving performance against C. difficile spores, MRSA, SARS-CoV-2 and other high-risk microorganisms.

Efficacy Table

Microorganism ≥ 4.0 Log Reduction ≥ 5.0 Log Reduction ≥ 6.0 Log Reduction
FUNGI• Candida auris• Candida albicans
BACTERIAL SPORESClostridium difficile
VIRUSES• Adenovirus
• Hepatitis A Virus
• Hepatitis C Virus ††
• Herpes Simplex Virus 2
• Human Coronavirus
• Measles Virus
• Respiratory Syncytial Virus
• Rhinovirus
• Rotavirus
• Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)**
• Ebola
• Enterovirus 68
• Herpes Simplex Virus 1
• Influenza A Virus (H1N1)
• Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
• Norovirus†††
• Poliovirus
BACTERIAAcinetobacter baumannii
Bordetella pertussis
Escherichia coli
Escherichia coli (carbapenem-resistant; CRE)
Enterococcus faecium (vancomycin-resistant; VRE)
Listeria monocytogenes
• Methicillin-resistant Staphylococcus aureus (MRSA)
Mycobacterium bovis (TB surrogate)
Pseudomonas aeruginosa
Salmonella enterica
Staphylococcus aureus
•Staphylococcus epidermis (coagulase-negative; CoNS)
Enterobacter aerogenes
Enterococcus aecalis
Klebsiella pneumoniae
Proteus mirabilis
Serratia marcescens

*Based on independent laboratory testing.           **Greater than 4-log reduction achieved in 5 minutes at 12 feet distance           †Between 3-and-4-log reduction achieved at 20 minutes           ††Via bovine viral diarrhea virus surrogate           Via feline calicivirus surrogate

360º Surface Coverage Confirmation

Proprietary UV Dose Verify™ confirms a germicidal UV-C dose calibrated to the UVDI-360 has reached any targeted surface.

UVDI-360 Running a Cycle in a Patient Room

Rapid UV-C Disinfection

Disinfection without workflow disruption. 5 to 10 minutes for an average-size patient room.

UVDI-360 Room Sanitizer Sensors

Designed for User Safety

Features including infrared heat-sensing motion sensors which shut off device immediately if people are present.

Easy to Operate

Simple remote and on-device operation.

Advanced Features for Advanced UV Disinfection

UVDI-360 Room Sanitizer

Powerful 158 cm Long Lamp Technology
Designed with four 158 cm maximum UV output lamps providing 360 degrees of UV radiation.

Aluminum Reflector Mast
Designed for maximum UV-C energy distribution.

Simple Remote Operation
Allows for remote cycle with a single push of a button.

Device has a range of 15 m through walls.

remote control

Touchscreen
Easy and intuitive touchscreen operating system.

Data Retention
Saves usage data for every cycle performed by device.

Safe to Use
Four infrared motion sensors prevent operation if movement is detected within the room.

Lightweight
Only weighs 40 kg - durable and easy to move

UVDI-360 Smart Data

Dr. Scrolling through Smart Data for International

Cloud-Based Analytics

Drive operational efficiency with easy-to-read dashboards sharing device and service information, overall usage data, custom reporting and real-time notifications.

Education Portal

Easily access product information, clinical evidence and training resources.

CMS (Content Management System)

Efficiently manage devices in-use and registered operators.